fixed errors on updated kinetics data

UF-IDD · Jul 5, 2020 · 76d3657 · 76d3657
1 parent ae14676
commit 76d3657
Showing 1 changed file with 20 additions and 20 deletions.
diff --git a/Data/Supplementary_Data_S1.csv b/Data/Supplementary_Data_S1.csv
@@ -2459,29 +2459,29 @@ Zhao et al. preprint,,Figure 1D,,,,China,SARS-CoV-2,ELISA,IgG,Cumulative proport
 15242938,,Table 1,Patient 20,,,,SARS-CoV-1,ELISA,IgM,Time to seroconversion,,,,17,Days,FALSE,,,
 15242938,,Table 1,Patient 20,,,,SARS-CoV-1,IFA,IgA,Time to seroconversion,,,,17,Days,FALSE,,,
 15242938,,Table 1,Patient 20,,,,SARS-CoV-1,ELISA,IgA,Time to seroconversion,,,,17,Days,FALSE,,,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,1–7,Days,TRUE,0,13,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,8–14,Days,TRUE,14,32,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,15–21,Days,TRUE,37,51,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,22–28,Days,TRUE,35,45,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,29–35,Days,TRUE,38,54,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,1-7,Days,TRUE,0,13,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,8-14,Days,TRUE,14,32,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,15-21,Days,TRUE,37,51,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,22-28,Days,TRUE,35,45,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,29-35,Days,TRUE,38,54,
 15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,<36,Days,TRUE,66,91,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,1–7,Days,TRUE,0,13,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,8–14,Days,TRUE,15,32,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,15–21,Days,TRUE,41,51,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,22–28,Days,TRUE,41,45,
-15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,29–35,Days,TRUE,50,54,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,1-7,Days,TRUE,0,13,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,8-14,Days,TRUE,15,32,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,15-21,Days,TRUE,41,51,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,22-28,Days,TRUE,41,45,
+15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,29-35,Days,TRUE,50,54,
 15096554,,Table 1,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,<36,Days,TRUE,91,91,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,49–56,Days,TRUE,4,18,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,57–63,Days,TRUE,3,17,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,64–70,Days,TRUE,3,24,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,71–77,Days,TRUE,2,12,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,78–84,Days,TRUE,0,13,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,49-56,Days,TRUE,4,18,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,57-63,Days,TRUE,3,17,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,64-70,Days,TRUE,3,24,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,71-77,Days,TRUE,2,12,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,78-84,Days,TRUE,0,13,
 15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgM,Proportion,,,,>84,Days,TRUE,0,6,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,49–56,Days,TRUE,18,18,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,57–63,Days,TRUE,17,17,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,64–70,Days,TRUE,24,24,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,71–77,Days,TRUE,12,12,
-15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,78–84,Days,TRUE,13,13,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,49-56,Days,TRUE,18,18,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,57-63,Days,TRUE,17,17,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,64-70,Days,TRUE,24,24,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,71-77,Days,TRUE,12,12,
+15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,78-84,Days,TRUE,13,13,
 15096554,,Table 2,,,,China,SARS-CoV-1,ELISA,IgG,Proportion,,,,>84,Days,TRUE,6,6,
 14715574,,Table 1,,,,,SARS-CoV-1,ELISA,anti-N,Proportion,,,,1-7,Days,TRUE,10,58,
 14715574,,Table 1,,,,,SARS-CoV-1,ELISA,anti-N,Proportion,,,,8-14,Days,TRUE,48,60,